Corona Remedies Ltd Share Price

Q: What is the share price of Corona Remedies Ltd today?

Corona Remedies Ltd share price as on 15 Dec 2025 is ₹0

Pharmaceuticals

NSE: CORONA Small Cap ISIN: INE02ZQ01018

As on 15 December 2025 at 19:56 IST

₹-

+ 0.00

(0.00%)

Sell Buy

Over 1 Month

None%

Over 6 Months

None%

Over 1 Year

None%

Over 3 Years

None%

Corona Remedies Ltd Summary

Close -

Open -

High -

Low -

Volume -

Net Turnover (in Cr) 0

52Wk High -

52Wk Low -

52Wk High / Low

Corona Remedies Ltd Fundamentals

Key Financial Data

Market Cap (in Cr)

EPS (TTM) 24.46

Book Value (BV) 99.04

Div. Yield -

P/E (TTM) -

Price/Book Value -

Delivery % -

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 20.40

ROE 27.45

Debt-Equity 0.23

Net Profit Margin 12.46

Operating Profit Margin 20.55

Corona Remedies Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	1,202.35	1,020.93	891.10
Total Expenses	1,004.21	902.46	780.44
Profit Before Tax	198.53	118.48	110.89
Profit After Tax	149.43	90.50	84.93
Operating Profit After Depreciation	208.75	132.91	114.93

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	369.88	383.70	184.59
Total Non Current Assets	590.99	540.66	303.54
Total Current Assets	338.87	289.92	291.49
Total Assets	929.86	830.58	595.02
Total Shareholder's Fund	606.34	480.41	408.52

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	190.50	156.76	102.70
Net Cash Used In Investing Activities	-83.84	-266.64	-50.28
Net Cash Used In Financing Activities	-106.59	98.55	-44.75

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020
Total Revenue	1,202.35	1,020.93	891.10	623.93	605.48
Total Expenses	1,004.21	902.46	780.44	624.72	527.13
Profit Before Tax	198.15	118.48	110.66	-0.79	78.35
Profit After Tax	149.05	90.50	84.70	-0.40	59.40
Operating Profit After Depreciation	208.75	132.91	114.93	3.93	79.41

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020
Fixed Assets	369.88	383.70	184.59	161.76	68.80
Total Non Current Assets	590.37	540.42	303.31	227.75	145.93
Total Current Assets	338.87	289.92	291.49	283.61	250.38
Total Assets	929.24	830.34	594.80	511.36	396.32
Total Shareholder's Fund	605.73	480.18	408.29	320.91	269.15

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	190.49	156.76	102.70	97.70	79.16
Net Cash Used In Investing Activities	-83.84	-266.64	-50.28	-65.81	-102.12
Net Cash Used In Financing Activities	-106.59	98.54	-44.75	-29.86	0.09

Particulars (in ₹ Cr.)	2025-06
Total Revenue	346.54
Total Expenses	276.96
Profit Before Tax	60.69
Profit After Tax	46.20
Operating Profit after Depreciation	71.60

No data available

Corona Remedies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 -

S2 -

S3 -

Pivot -

R1 -

R2 -

R3 -

Moving Average

20 SMA -

50 SMA -

100 SMA -

200 SMA -

Corona Remedies Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,426.90	₹1,70,614
Torrent Pharmaceuticals Ltd	₹3,789.25	₹1,28,239.68
Cipla Ltd	₹1,517.20	₹1,22,555.05
Dr Reddys Laboratories Ltd	₹1,279.65	₹1,06,803.47

Corona Remedies Ltd Top Mutal Funds Invested

No data available

Corona Remedies Ltd News

Corona Remedies spurts on market debut

Shares of Corona Remedies were currently trading at Rs 1,465.55 at 10:20 IST on the BSE, representing a premium of 38% as compared with the issue price of Rs 1,062.

15 Dec 2025, 10:25 am

Shares of Corona Remedies list in B group

15 Dec 2025, 09:30 am

Corona Remedies Ltd Stock Analysis

Annual revenue for Corona Remedies Ltd increased by 17.77% to ₹1,202.35 crore in FY 2025 from ₹1,020.93 crore in FY 2024.
Annual Net Profit for Corona Remedies Ltd increased by 64.70% to ₹149.05 crore in FY 2025 from ₹90.50 crore in FY 2024.
Promoter Shareholding in Corona Remedies Ltd remains unchanged by 0.00% in the most recent quarter, from 72.50% in December 2025 to 72.50% in December 2025.
Corona Remedies Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of 6.10% as of the last trading session.
Corona Remedies Ltd share price moved down by 100.00% from its previous close of INR ₹1,062. The latest Corona Remedies Ltd share price is INR ₹0.
Corona Remedies Ltd share price today has been at a low of 1,431.50 and a high of 1,497.80. Over the past 52 weeks, the Corona Remedies Ltd share price has seen a low of 1,431.50 and a high of 1,497.80.